The hepatic expression and circulating levels of FGF21 are consistency reported to be higher in NAFLD, and are associated with enhanced hepatic necroinflammation and fibrosis (276–280). This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.